<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-28T19:00:27Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/2904" metadataPrefix="dim">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/2904</identifier><datestamp>2025-02-19T08:55:15Z</datestamp><setSpec>com_10324_1138</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1226</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="24ed3565b6d86c5d" confidence="500" orcid_id="">Río Sola, María Lourdes del</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="32a3c8b34c41d6c0" confidence="600" orcid_id="">González Fajardo, José Antonio</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="9995f4b7e1c91381" confidence="500" orcid_id="0000-0002-2195-1679">Vaquero Puerta, Carlos</dim:field>
<dim:field mdschema="dc" element="date" qualifier="accessioned">2013-06-04T07:21:18Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="available">2013-06-04T07:21:18Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="issued">2012</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="citation" lang="es">Annals of Vascular Surgery</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="uri">http://uvadoc.uva.es/handle/10324/2904</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="doi" lang="es">10.1016/j.avsg.2011.02.051</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="publicationfirstpage" lang="es">1</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="publicationlastpage" lang="es">10</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="publicationtitle" lang="es">Annals of Vascular Surgery</dim:field>
<dim:field mdschema="dc" element="description" lang="es">Producción Científica</dim:field>
<dim:field mdschema="dc" element="description" qualifier="abstract" lang="es">Background: To determine the effect of aspirin on ulcer healing rate in patients with chronic&#xd;
venous insufficiency, and to establish prognostic factors that influence ulcer evolution.&#xd;
Methods: Between 2001 and 2005, 78 patients with ulcerated lesions of diameter >2 cm and&#xd;
associated with chronic venous insufficiency were evaluated in our hospital. Of these, 51 patients&#xd;
(22 men, 29 women) with mean age of 60 years (range: 36e86) were included in a prospective&#xd;
randomized trial with a parallel control group. The treatment group received 300 mg of aspirin and&#xd;
the control group received no drug treatment; in both groups, healing was associated with standard&#xd;
compression therapy. During follow-up, held weekly in a blinded fashion, there was ulcer&#xd;
healing as well as cases of recurrence. Results were analyzed by intention-to-treat approach.&#xd;
Cure rate was estimated using KaplaneMeir survival analysis, and the influence of prognostic&#xd;
factors was analyzed by applying the Cox proportional hazards model.&#xd;
Results: In the presence of gradual compression therapy, healing occurred more rapidly in&#xd;
patients receiving aspirin versus the control subjects (12 weeks in the treated group vs. 22&#xd;
weeks in the control group), with a 46% reduction in healing time. The main prognostic factor&#xd;
was estimated initial area of injury (P ¼ 0.032). Age, sex, systemic therapy, and infection&#xd;
showed little relevance to evolution.&#xd;
Conclusions: The administration of aspirin daily dose of 300 mg shortens the healing time of&#xd;
ulcerated lesions in the chronic venous insufficiency (CVI). The main prognostic factor for healing&#xd;
of venous ulcerated lesions is the initial surface area of the ulcer.</dim:field>
<dim:field mdschema="dc" element="format" qualifier="mimetype" lang="es">application/pdf</dim:field>
<dim:field mdschema="dc" element="language" qualifier="iso" lang="es">eng</dim:field>
<dim:field mdschema="dc" element="publisher" lang="es">Universidad de Valladolid. Facultad de Medicina</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="accessRights" lang="es">info:eu-repo/semantics/openAccess</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="uri">http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dim:field>
<dim:field mdschema="dc" element="rights">Attribution-NonCommercial-NoDerivs 3.0 Unported</dim:field>
<dim:field mdschema="dc" element="subject" lang="es">Insuficiencia venosa crónica</dim:field>
<dim:field mdschema="dc" element="subject" lang="es">Aspirina</dim:field>
<dim:field mdschema="dc" element="subject" lang="es">Úlceras</dim:field>
<dim:field mdschema="dc" element="title" lang="es">Influence of aspirin therapy in the ulcer associated with chronic venous insufficiency</dim:field>
<dim:field mdschema="dc" element="type" lang="es">info:eu-repo/semantics/article</dim:field>
<dim:field mdschema="dc" element="peerreviewed" lang="es">SI</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>